SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Roald Amundsen

PatientRoald Amundsen
Date of birth1970-07-16
IdentifiersMRN HR-EX003-SYN; SSN (made up) 000-03-1259
Document date2026-05-05
AuthorIngrid Solheim-Achebe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Twelve-week review of finger pain on duloxetine. [S]

History of Present Illness

Mr. Amundsen returns six weeks after starting duloxetine; he has taken 60 mg daily for five weeks. The mild nausea of the first days has gone, and he has had no drowsiness, dizziness or sweating. His average finger pain over the past week is 3 of 10; the cold attacks are shorter and less frequent, though the spring weather is milder too. He sleeps through most nights. He uses capsaicin cream only on cold days. He can manage buttons and keys outdoors with liner gloves. He did not have the blood test that was meant to be done two to four weeks after starting duloxetine. [S]

ElementDetail
Finger painAverage 3 of 10 over the past week
Medicine effectsEarly nausea gone; no drowsiness, dizziness or sweating
SleepSleeping through most nights
FunctionManages buttons and keys outdoors with liner gloves

Review of Systems

SystemResultFinding
NeurologicalPositiveFinger burning in the cold, much less; no dizziness
GastrointestinalNegativeNo nausea now; normal appetite
PsychiatricNegativeMood better; PHQ-9 3

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Capsaicin 0.075% cream, a small amount rubbed into the painful fingers four times a day; wash hands after use and keep away from the eyesfour times a dayTopical route2026-02-24activeS
Duloxetine 30 mg delayed-release capsule, one capsule by mouth daily for one weekonce daily for one weekOral route2026-03-24 to 2026-03-31completedS
Duloxetine 60 mg delayed-release capsule, one capsule by mouth daily; do not stop suddenlyonce dailyOral route2026-03-31activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-05-05Body height183cmS
2026-05-05Body weight78.6kgS
2026-05-05Body mass index (BMI) [Ratio]23.5kg/m2S
2026-05-05Systolic blood pressure132mm[Hg]S
2026-05-05Diastolic blood pressure82mm[Hg]S
2026-05-05Heart rate66/minS
2026-05-05Respiratory rate14/minS
2026-05-05Body temperature36.6CelS
2026-05-05Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-05Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
2026-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-05-05Sodium [Moles/volume] in Serum or Plasma139mmol/L136-145 mmol/LNormalS
2026-05-05Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma27U/L7-52 U/LNormalS

Physical Exam

Vital signs recorded on 2026-05-05; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 132/82, pulse 66, weight 78.6 kg
HandsFingertips cool; skin intact
NeurologicalAlert; no tremor

Problems

ProblemClinical statusVerificationCodeProvenance
Burning pain, numbness and tingling in the fingers of both hands, brought on by cold for many winters and worse this winter, with the fingers turning white then blue then red in the cold; average pain 6 of 10; cause not yet established at intake; nerve conduction studies and neurology consultation requestedresolvedconfirmed R20.2S — Synthetic presenting problem anchored to his documented frostbite of the fingers; superseded by the diagnosis at the neurology consultation.
Cold-induced neuropathic pain and cold sensitivity of the fingers of both hands, a late sequela of frostbite in early adulthood: small-fiber pattern with normal nerve conduction studies, cold allodynia and reduced pinprick at the fingertips, and cold-induced vasospasmactiveconfirmed M79.2S — Synthetic modern diagnosis made at the neurology consultation, linked to his documented frostbite of the fingers.
Old fracture of the upper end of the right humerus, set at sea and rehabilitated without surgery: forward flexion and abduction limited to about 120 degrees, without pain at restactiveconfirmed S42.201SS — Synthetic modern coding of his documented shoulder fracture; the range of movement is synthetic.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPain severity (0 to 10 numeric rating) and overall improvementEvery review, and early after starting or changing a medicineCompleted todayAverage 3 of 10, from 6 at intake
Medication safetyAdverse effects, especially drowsiness, dizziness and nauseaEvery review, and early after starting or changing a medicineCompleted todayEarly nausea only; no drowsiness or dizziness
ExaminationDaily activities and participation: fine hand tasks in the cold, driving, flyingEvery review, and early after starting or changing a medicineCompleted todayManages fine tasks outdoors with gloves; driving
SurveyMood (PHQ-9) and anxietyEvery review, and early after starting or changing a medicineCompleted todayPHQ-9 3
ExaminationSleep qualityEvery review, and early after starting or changing a medicineCompleted todaySleeping through most nights
ExaminationBlood pressureBefore starting duloxetine and periodically on itCompleted today132/82 mmHg, up from 126/78 before duloxetine; recheck at the next visit
LaboratorySodium and liver enzyme (ALT) on duloxetineBaseline, then once in the first weeks of treatmentCompleted todaySodium 139 mmol/L and ALT 27 U/L. Protocol deviation: the test ordered for two to four weeks after starting duloxetine was not drawn, because no date was booked and it was missed at the preventive visit; it was drawn today, six weeks after starting. No harm resulted: both results are normal. Corrective action: book the blood test with a date when a medicine needing monitoring is started
Medication safetyInteractions: no tramadol or other serotonergic drugs; caution with oral NSAIDs; alcoholEvery reviewCompleted todayNo new medicines; rare alcohol
Self-managementSkin of the fingers and cold protectionEvery review, and early after starting or changing a medicineCompleted todaySkin intact

Goal progress:

Guideline basis: Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173) (2013, updated 2020); Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024)

Follow-up: Review in about five weeks, with a blood pressure check. Next scheduled visit 2026-06-09: seventeen-week review: finger pain, the ankle sprain, and the risks of an Arctic air search flight. [S]